Bioengineered Bugs A 'Brisk Trade' In Applied and Basic Entomology

if (n == null) The Scientist - Beyond the Fruit Fly The Scientist 9[18]:13, Sep. 18, 1995 Research Beyond the Fruit Fly By Karen Young Kreeger Of all the animal species described thus far by scientists, insects account for nearly five-sixths. Nearly 1 million are already identified, with taxonomists estimating another 1 million to go. Despite their ubiquity on Earth, the study of insects has only recently been married to the explosion of molecular biologic

Written byKaren Young Kreeger
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


Research

By Karen Young Kreeger

Of all the animal species described thus far by scientists, insects account for nearly five-sixths. Nearly 1 million are already identified, with taxonomists estimating another 1 million to go. Despite their ubiquity on Earth, the study of insects has only recently been married to the explosion of molecular biological tools that have come on the scene in the last 15 years.

Sidebar: Resources for Entomologists

David A. O'Brochta, an associate professor at the University of Maryland Biotechnology Institute's Center for Agricultural Biotechnology, observes that the increasing interest in the molecular biology of insects stems mostly from their medical and agricultural significance: "I think the genetic-engineering technology developed in my and other labs is going to be for the purposes of studying insects because they're pests or are beneficial. This technology will be used for making them better at what they do -- a better ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies